Abivax SA Sponsored ADR
ABVX Healthcare Biotechnology
In the quarter to June 2026, EPS fell 98.8%, free cash flow fell 48.3% and total debt fell 98.5%, each against the same quarter a year earlier.
Follow ABVX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
700.02 | 608.81 | 584.56 | 477.50 |
Receivables |
23.87 | 14.87 | 16.11 | 19.70 | |
Total current assets |
723.89 | 623.68 | 600.67 | 497.20 | |
Property, Plant, Equpment (Net) |
2.24 | 2.36 | 2.09 | 1.77 | |
Long-Term Investments |
5.96 | 6.06 | 6.31 | 6.35 | |
Goodwill and Intangible Assets (Total) |
29.25 | 28.31 | 29.29 | 29.10 | |
Long-term assets (Other) |
0.84 | 0.71 | 2.01 | 3.00 | |
Total non-current assets |
38.29 | 37.45 | 39.70 | 40.21 | |
Total Assets |
762.18 | 661.12 | 640.38 | 537.41 | |
Accounts Payable |
35.09 | 42.49 | 34.54 | 45.36 | |
Accrued Expenses |
9.27 | 8.07 | 15.79 | 8.94 | |
Current Part of Debt |
34.37 | 1.47 | 1.29 | 1.25 | |
Other current liabilities |
13.34 | 19.27 | 21.21 | 27.80 | |
Total current liabilities |
92.06 | 71.30 | 72.84 | 83.35 | |
Long Term Debt (Total) |
19.27 | 0.63 | 0.41 | 0.16 | |
Pension and Post-Retirement Liabilities |
0.99 | 0.71 | 0.75 | 0.81 | |
Long Term Tax Liability (Deferred) |
— | 6.62 | 7.11 | — | |
Non-current Liabilities (Other) |
52.27 | 66.85 | 56.48 | 27.23 | |
Total non-current liabilities |
72.53 | 74.80 | 64.74 | 28.20 | |
Total liabilities |
164.60 | 146.10 | 137.58 | 111.55 | |
Additional Paid In Capital |
1,378.75 | 1,347.04 | 1,394.04 | 1,428.57 | |
Common Stock (Net) |
0.91 | 0.89 | 0.93 | 0.93 | |
Retained Earnings |
(782.94) | (835.52) | (894.55) | (1,005.69) | |
Shareholders Equity (Other) |
0.87 | 2.61 | 2.37 | 2.06 | |
Common Equity (Total) |
597.59 | 515.02 | 502.80 | 425.86 | |
Shareholders Equity (Total) |
597.59 | 515.02 | 502.80 | 425.86 | |
Shareholders Equity and Liabilities (Total) |
762.18 | 661.12 | 640.38 | 537.41 | |
Shares (Common) |
77.83 | 78.54 | 79.29 | 79.82 | |
Shareholders Equity (Tangible) |
568.33 | 486.71 | 473.51 | 396.76 | |
Net Debt |
(646.38) | (606.71) | (582.87) | (476.09) | |
Total Debt |
53.64 | 2.10 | 1.69 | 1.41 |